Small cell carcinoma of the urinary bladder

Mukta Pant-Purohit, Antonio Lopez-Beltran, Rodolfo Montironi, Gregory T. MacLennan, Liang Cheng

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Small cell carcinoma of the urinary bladder (SCCUB) is a rare and aggressive cancer of the bladder. SCCUB is part of neuroendocrine family of tumors that affect several organ systems including respiratory, gastrointestinal and male and female genitourinary tract. SCCUB affect males predominantly with common risk factors include smoking, bladder calculi, bladder manipulation, and chronic cystitis. Prognosis of SCCUB remains poor due to high metastatic potential and lack of symptoms in earlier stages of the disease. Pathogenesis of the disease is linked to loss of genetic material, hypermethylation of tumor suppressors and at times amplification of the chromosomal regions carrying oncogenes. Majority of cases are treated with local resection of the tumor with neoadjuvant or adjuvant platinum-based chemotherapy regimen. Radiation therapy is used as alternative to radical cystectomy or as palliative measure. This article provides epidemiology, molecular pathogenesis, histochemistry, and current management options for SCCUB. Furthermore we reviewed all recent studies involving advancement in targeted molecular therapy for neuroendocrine tumors.

Original languageEnglish
Pages (from-to)217-221
Number of pages5
JournalHistology and Histopathology
Volume25
Issue number2
StatePublished - Feb 2010

Fingerprint

Small Cell Carcinoma
Urinary Bladder
Neuroendocrine Tumors
Molecular Targeted Therapy
Urinary Bladder Calculi
Cystitis
Molecular Epidemiology
Cystectomy
Platinum
Oncogenes
Urinary Bladder Neoplasms
Respiratory System
Neoplasms
Radiotherapy
Smoking
Drug Therapy
Genes

Keywords

  • Differential diagnosis
  • Molecular genetics
  • Neoplasms small cell carcinoma
  • Prognosis 7
  • Urinary bladder

ASJC Scopus subject areas

  • Histology
  • Pathology and Forensic Medicine

Cite this

Pant-Purohit, M., Lopez-Beltran, A., Montironi, R., MacLennan, G. T., & Cheng, L. (2010). Small cell carcinoma of the urinary bladder. Histology and Histopathology, 25(2), 217-221.

Small cell carcinoma of the urinary bladder. / Pant-Purohit, Mukta; Lopez-Beltran, Antonio; Montironi, Rodolfo; MacLennan, Gregory T.; Cheng, Liang.

In: Histology and Histopathology, Vol. 25, No. 2, 02.2010, p. 217-221.

Research output: Contribution to journalArticle

Pant-Purohit, M, Lopez-Beltran, A, Montironi, R, MacLennan, GT & Cheng, L 2010, 'Small cell carcinoma of the urinary bladder', Histology and Histopathology, vol. 25, no. 2, pp. 217-221.
Pant-Purohit M, Lopez-Beltran A, Montironi R, MacLennan GT, Cheng L. Small cell carcinoma of the urinary bladder. Histology and Histopathology. 2010 Feb;25(2):217-221.
Pant-Purohit, Mukta ; Lopez-Beltran, Antonio ; Montironi, Rodolfo ; MacLennan, Gregory T. ; Cheng, Liang. / Small cell carcinoma of the urinary bladder. In: Histology and Histopathology. 2010 ; Vol. 25, No. 2. pp. 217-221.
@article{8ca3c17f342a42aba1deeb5b52aa4b47,
title = "Small cell carcinoma of the urinary bladder",
abstract = "Small cell carcinoma of the urinary bladder (SCCUB) is a rare and aggressive cancer of the bladder. SCCUB is part of neuroendocrine family of tumors that affect several organ systems including respiratory, gastrointestinal and male and female genitourinary tract. SCCUB affect males predominantly with common risk factors include smoking, bladder calculi, bladder manipulation, and chronic cystitis. Prognosis of SCCUB remains poor due to high metastatic potential and lack of symptoms in earlier stages of the disease. Pathogenesis of the disease is linked to loss of genetic material, hypermethylation of tumor suppressors and at times amplification of the chromosomal regions carrying oncogenes. Majority of cases are treated with local resection of the tumor with neoadjuvant or adjuvant platinum-based chemotherapy regimen. Radiation therapy is used as alternative to radical cystectomy or as palliative measure. This article provides epidemiology, molecular pathogenesis, histochemistry, and current management options for SCCUB. Furthermore we reviewed all recent studies involving advancement in targeted molecular therapy for neuroendocrine tumors.",
keywords = "Differential diagnosis, Molecular genetics, Neoplasms small cell carcinoma, Prognosis 7, Urinary bladder",
author = "Mukta Pant-Purohit and Antonio Lopez-Beltran and Rodolfo Montironi and MacLennan, {Gregory T.} and Liang Cheng",
year = "2010",
month = "2",
language = "English",
volume = "25",
pages = "217--221",
journal = "Histology and Histopathology",
issn = "0213-3911",
publisher = "Histology and Histopathology",
number = "2",

}

TY - JOUR

T1 - Small cell carcinoma of the urinary bladder

AU - Pant-Purohit, Mukta

AU - Lopez-Beltran, Antonio

AU - Montironi, Rodolfo

AU - MacLennan, Gregory T.

AU - Cheng, Liang

PY - 2010/2

Y1 - 2010/2

N2 - Small cell carcinoma of the urinary bladder (SCCUB) is a rare and aggressive cancer of the bladder. SCCUB is part of neuroendocrine family of tumors that affect several organ systems including respiratory, gastrointestinal and male and female genitourinary tract. SCCUB affect males predominantly with common risk factors include smoking, bladder calculi, bladder manipulation, and chronic cystitis. Prognosis of SCCUB remains poor due to high metastatic potential and lack of symptoms in earlier stages of the disease. Pathogenesis of the disease is linked to loss of genetic material, hypermethylation of tumor suppressors and at times amplification of the chromosomal regions carrying oncogenes. Majority of cases are treated with local resection of the tumor with neoadjuvant or adjuvant platinum-based chemotherapy regimen. Radiation therapy is used as alternative to radical cystectomy or as palliative measure. This article provides epidemiology, molecular pathogenesis, histochemistry, and current management options for SCCUB. Furthermore we reviewed all recent studies involving advancement in targeted molecular therapy for neuroendocrine tumors.

AB - Small cell carcinoma of the urinary bladder (SCCUB) is a rare and aggressive cancer of the bladder. SCCUB is part of neuroendocrine family of tumors that affect several organ systems including respiratory, gastrointestinal and male and female genitourinary tract. SCCUB affect males predominantly with common risk factors include smoking, bladder calculi, bladder manipulation, and chronic cystitis. Prognosis of SCCUB remains poor due to high metastatic potential and lack of symptoms in earlier stages of the disease. Pathogenesis of the disease is linked to loss of genetic material, hypermethylation of tumor suppressors and at times amplification of the chromosomal regions carrying oncogenes. Majority of cases are treated with local resection of the tumor with neoadjuvant or adjuvant platinum-based chemotherapy regimen. Radiation therapy is used as alternative to radical cystectomy or as palliative measure. This article provides epidemiology, molecular pathogenesis, histochemistry, and current management options for SCCUB. Furthermore we reviewed all recent studies involving advancement in targeted molecular therapy for neuroendocrine tumors.

KW - Differential diagnosis

KW - Molecular genetics

KW - Neoplasms small cell carcinoma

KW - Prognosis 7

KW - Urinary bladder

UR - http://www.scopus.com/inward/record.url?scp=75149192032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75149192032&partnerID=8YFLogxK

M3 - Article

C2 - 20017108

AN - SCOPUS:75149192032

VL - 25

SP - 217

EP - 221

JO - Histology and Histopathology

JF - Histology and Histopathology

SN - 0213-3911

IS - 2

ER -